Home › Therapeutic areas › Infectious Disease › Pneumococcal Pneumonia
Pneumococcal Pneumonia (2 companies)
Companies with an active program in Pneumococcal Pneumonia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ADMA | Adma Biologics | ImmunologyInfectious Disease Rare | 1 | Approved | $2.82B | 4 |
| PCVX | Vaxcyte | Infectious Disease | 1 | Phase 3 | $10.1B | 7 |
No companies match.